L to R Ameve Sharma, Founder, Kapiva and Dr. R. Govindarajan, Chief Innovation Officer, Kapiva, asserting the Kapiva Innovation Fund
D2C wellness startup Kapiva has launched the ₹50-crore Kapiva Innovation Fund (KIF). The fund will likely be deployed throughout 15-30 startups over 4 years, with follow-on investments in choose instances, mentioned Ameve Sharma, Founder, Kapiva.
“We expect this to be round a three-to-four-year deployment. The funnel will likely be bigger, most likely within the subsequent yr or two. There’ll be possibly about 20 to 30 investments that we do, ranging anyplace from ₹50 lakh to ₹2 crore. However the true doubling down will occur after that,” Sharma mentioned.
KIF will again tasks throughout academia, labs and startups that target R&D in Ayurvedic science and create clinically validated options for real-world well being issues.
Preliminary cheque sizes will vary from ₹50 lakh to ₹1 crore, with Kapiva remaining open to doubling down on promising ventures.
KIF will again tasks throughout academia, labs, and startups that target R&D in Ayurvedic science and create clinically validated options for real-world well being issues.
Sharma mentioned, “This fund is a long-term wager on that future. By investing as much as ₹50 crore in analysis, collaborations and new applied sciences, Kapiva needs to assist construct an ecosystem the place Ayurvedic merchandise are developed and examined like fashionable drugs.”
Dr. R. Govindarajan, Chief Innovation Officer, Kapiva, mentioned, “If Ayurveda has to take a seat on the identical desk as fashionable drugs, it have to be examined with the identical self-discipline. Via the Kapiva Innovation Fund, we need to open that ecosystem to researchers, clinicians, and entrepreneurs, share our infrastructure and mentor high-quality tasks, in order that sturdy Ayurvedic science can transfer from paper to merchandise and attain hundreds of thousands of individuals.”
Printed on January 21, 2026
